7.40
Finanzdaten der Cadrenal Therapeutics Inc-Aktie (CVKD)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
|
|
26.79%
2.7338
|
3.7343 | 3.928 | 2.46 | 2.4666 |
| Operating Income/Loss |
26.79%
-2.7338
|
-3.7343 | -3.928 | -2.46 | -2.4666 |
| Nonoperating Income/Loss |
28.22%
0.0481
|
0.067 | 0.0826 | 0.0521 | 0.0736 |
| Income/Loss From Continuing Operations Before Tax |
26.77%
-2.6857
|
-3.6673 | -3.8454 | -2.4078 | -2.393 |
| Income/Loss From Continuing Operations After Tax |
26.77%
-2.6857
|
-3.6673 | -3.8454 | -2.4078 | -2.393 |
|
|
26.77%
-2.6857
|
-3.6673 | -3.8454 | -2.4078 | -2.393 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
4.20%
2.044
|
1.9616 | 1.8441 | 1.104 | 16.01 |
| Diluted Average Shares |
4.20%
2.044
|
1.9616 | 1.8441 | 1.104 | 16.01 |
| Basic Earnings Per Share |
29.95%
-1.31
|
-1.87 | -2.09 | -2.18 | -0.15 |
| Diluted Earnings Per Share |
29.95%
-1.31
|
-1.87 | -2.09 | -2.18 | -0.15 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):